F. Samuel Eberts III
Legal Director
Sam Eberts is an accomplished CEO and board leader with over thirty years of experience with companies in the healthcare, consumer, and industrial services markets. With deep management experience across various administrative and operational roles, Sam is an experienced senior executive with Fortune 500 companies and start-ups with experience working in product design, government relations, corporate communications, regulatory and payor strategies, compliance, public and private capital markets, M&A transactions, and exit strategies. Sam has managed over $30 billion in acquisitions, spin-offs, and debt offerings. He has made acquisitions on 4 continents and in industries including diagnostics, life sciences, medical distribution, and consumer products. He has closed well over 170 deals ranging in size from $15 million to $6 billion and raised around $100 million in funding.
Sam is a partner with Market Street Healthcare Partners, an independent, private equity sponsor focused on healthcare investments based in Dallas, Texas. He is a Senior Advisor to Invescore Ltd., an investment bank with offices in London and New York. Sam is also a Senior Lecturing Fellow at Duke University School of Law teaching law and business strategy. He founded the Daerter Group, an advisory firm focused on start-ups in health care. In 2019, Sam retired as the Chief Legal Officer, Corporate Secretary, and Senior Vice President of Global Corporate Affairs for LabCorp (NYSE: LH) with enterprise-wide responsibility for the legal, compliance, corporate secretary, public policy, communications, privacy, and security functions.
In 2023 after serving on the board of Aquyre Biosciences, Sam was appointed CEO and Board Chair. With offices in Weston, Massachusetts and Paris, France; Aquyre is the creator of CelTivity, the industry leader in biopsy adequacy assessment. Powered by Dynamic Cell Imaging, CelTivity measures intracellular and metabolic activity of cancer cells. Sam led a reorganization and recapitalization of the company and the restructuring of R&D, manufacturing and sales to prepare the company for the launch of its next generation system which is augmented with artificial intelligence and improved imaging systems. After completing the restructuring of the company and implementing a CEO succession plan, Sam retired from Aquyre.
Sam is the Lead Independent Director and Chair of the Nominating and Corporate Governance Committee of DIH Inc. (NASDAQ: DHAI), a leading global robotics and virtual reality provider in the rehabilitation and human performance industry. He serves as an Independent Director and Board Chair of Synergy VetPet, a veterinary consolidator in Chicago, Illinois; and as a Director for Duo Technologies, a clean energy company in Naples, Florida. Sam is Chair of the board of advisors for Thermaissance, based in Mumbai, India; a global manufacturer of smart textiles that can successfully inactivate various viruses and bacteria. He is Board Chair of Easter Seals/UCP of North Carolina and Virginia, and Board Chair of Action in Africa headquartered in Aspen, Colorado. Sam also serves on the Leadership Council of the National Small Business Association in Washington D.C.; the Board of Trustees for Endicott College in Beverly, Massachusetts; and the advisory board for the Woodrow Wilson Center in Washington, D.C. In addition to serving as Chairman of the Board of Aquyre Biosciences, Sam served as an Independent Director and Chair of the Compensation and Special Committees for VB Acquisition Corp. (NASDAQ: VBOCU), a healthcare SPAC. He was previously a partner with MedCap Funds, a global health care technology fund and served on the fund’s investment committee.
Sam has served on the board of Alpha Marketing, a channel marketing agency in Raleigh, North Carolina; the Alamance Community College Foundation in Graham, North Carolina; and the World Policy Institute in New York. Sam also served on the Health Care Policy Leadership Council at Harvard University Kennedy School and the Corporate Governance Forum at Harvard Law School. Sam is a frequent speaker on healthcare and leadership and has served as a guest lecturer at Harvard University Kennedy School of Government, Duke University School of Law, Wake Forest University School of Law, Baylor University School of Medicine, and the University of Minnesota Carlson School of Management. He has also served as an Adjunct Associate Professor at the University of Texas School of Public Health: Division of Management, Policy, and Community Health.